The Australian government has ordered 84.8 million doses of two CCP virus vaccine candidates developed by the University of Queensland and Oxford University.
Most of the vaccine units will be manufactured in Australia and available for release from mid-2021. About 3.8 million vaccine units will be imported and available in early 2021.
